Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia

References

• Rowley J. D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–3
   PubMed Web of Science ®Google Scholar
• De Klein A., Van Kessel A. G., Grosveld G., Bartram C. R., Hagemeijer A., Bootsma D., et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1982; 300: 765–7
   PubMed Web of Science ®Google Scholar
• Vardiman J. W., Harris N. L., Brunning R. D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–302
   PubMed Web of Science ®Google Scholar
• Gordon M. Y., Dowding C. R., Riley G. P., Goldman J. M., Greaves M. F. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342–4
   PubMed Web of Science ®Google Scholar
• Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65–71
   PubMedGoogle Scholar
• Vacca A., Ribatti D., Presta M., Minischetti M., Iurlaro M., Ria R., et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase‐2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064–73
   PubMed Web of Science ®Google Scholar
• Pádro T., Ruiz S., Bieker R., Bürger H., Steins M., Kienast J., et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637–44
   PubMed Web of Science ®Google Scholar
• Molica S., Vacca A., Ribatti D., Cuneo A., Cavazzini F., Levato D., et al. Prognostic value of enhanced bone marrow angiogenesis in early B‐cell chronic lymphocytic leukemia. Blood 2002; 100: 3344–51
   PubMed Web of Science ®Google Scholar
• Salven P. Angiogenesis in lymphoproliferative disorders. Acta Haematol 2001; 106: 184–9
   PubMed Web of Science ®Google Scholar
• Lundberg L. G., Lerner R., Sundelin P., Rogers R., Folkman J., Palmblad J. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000; 157: 15–19
   PubMed Web of Science ®Google Scholar
• Palmblad J., Lerner R., Lundberg L. G. Vascular density, intracellular VEGF and bFGF positivity as prognostic factors in polycythemia vera and chronic myelocytic leukemia. Blood 2000; 96: 257b
   Google Scholar
• Aguayo A., Kantarjian H., Manshouri T., Gidel C., Estey E., Thomas D., et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240–5
   PubMed Web of Science ®Google Scholar
• Krauth M. T., Simonitsch I., Mayerhofer M., Sperr W. R., Sillaber C., Schneeweiss B., et al. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with phase of disease. Am J Clin Pathol 2004; 121: 473–81
   PubMed Web of Science ®Google Scholar
• Verstovsek S., Lunin S., Kantarjian H., Manshouri T., Faderl S., Cortes J., et al. Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia. Leuk Res 2003; 27: 661–9
   PubMed Web of Science ®Google Scholar
• Di Raimundo F., Fichera E., Azzaro M. P., Stagno F., Palumbo G. A. Low serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in IFN‐treated chronic myeloid leukemia (CML) patients. Blood 2000; 96: 253b
   Google Scholar
• Di Raimondo F., Palumbo G. A., Molica S., Guistolisi R. Angiogenesis in chronic myeloproliferative disorders. Acta Haematol 2001; 106: 177–83
   PubMed Web of Science ®Google Scholar
• Janowska‐Wieczorek A., Majka M., Marquez‐Curtis L., Wertheim J. A., Turner A. R., Ratajczak M. Z. Bcr‐abl‐positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia 2002; 6: 1160–6
   Google Scholar
• Leung D. W., Cachianes G., Kuang W. J., Goeddel D. V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–9
   PubMed Web of Science ®Google Scholar
• Shibuya M. Structure and function of VEGF/VEGF‐receptor system involved in angiogenesis. Cell Structure Function 2001; 26: 25–35
   PubMed Web of Science ®Google Scholar
• Dias S., Shmelkov S. V., Lam G., Rafii S. VEGF165 promotes survival of leukemic cells by Hsp90‐mediated induction of Bcl‐2 expression and apoptosis inhibition. Blood 2000; 99: 2532–40
   Google Scholar
• Fiedler W., Graeven U., Ergun S., Verago S., Kilic N., Stockschlader M., et al. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia. Blood 1997; 89: 1870–5
   PubMed Web of Science ®Google Scholar
• Bellamy W. T., Richter L., Sirjani D., Roxas C., Glinsmann‐Gibson B., Frutiger Y., et al. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes. Blood 2001; 97: 1427–34
   PubMed Web of Science ®Google Scholar
• Bellamy W. T., Richter L., Frutiger Y., Grogan T. M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Research 1999; 59: 728–33
   PubMed Web of Science ®Google Scholar
• Mayerhofer M., Valent P., Sperr W. R., Griffin J. D., Sillaber C. BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor‐1alpha, through a pathway involving phosphoinositide 3‐kinase and the mammalian target of rapamycin. Blood 2002; 100: 3767–75
   PubMed Web of Science ®Google Scholar
• Nakamura T., Teramoto H., Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchimal hepatocytes in primary cultures. Proc Natl Acad Sci 1986; 83: 6489–93
   PubMed Web of Science ®Google Scholar
• Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast‐derived modulator of epithelial cell motility. Nature 1987; 327: 239–42
   PubMed Web of Science ®Google Scholar
• Kmiecik T. E., Keller J. R., Rosen E., Vande Woude G. F. Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood 1992; 80: 2454–7
   PubMed Web of Science ®Google Scholar
• Miyazawa K., Tsubouchi H., Naka D., Iakahashi K., Okigaki M., Arakaki N., et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967–73
   PubMed Web of Science ®Google Scholar
• Naldini L., Weidner K. M., Vigna E., Sachs M., Gaudino G., Bardelli A., et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the Met receptor. EMBO J 1991; 10: 2867–78
   PubMed Web of Science ®Google Scholar
• Jiang W., Hiscox S., Matsumoto K., Nakamura T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 1999; 29: 209–48
   PubMed Web of Science ®Google Scholar
• Pons E., Uphoff C. C., Drexler H. G. Expression of hepatocyte growth factor and its receptor c‐met in human leukemia‐lymphoma cell lines. Leuk Res 1998; 22: 797–804
   PubMedGoogle Scholar
• Hino M., Inaba M., Goto H., Nishizawa Y., Tatsumi N., Nishino T., et al. Hepatocyte growth factor levels in bone marrow plasma of patients with leukaemia and its gene expression in leukaemic blast cells. Br J Cancer 1996; 73: 119–23
   PubMedGoogle Scholar
• Gwang Kim J., Kyun Sohn S., Hwan Kim D., Ho Baek J., Young Lee N., Soo Suh J., et al. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymph 2005; 46: 885–91
   PubMed Web of Science ®Google Scholar
• Weimar I. S., Voermans C., Bourhis J. H., Miranda N., Van den Berk P. C. M., Nakamura T., et al. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells. Leukemia 1998; 12: 1195–203
   PubMed Web of Science ®Google Scholar
• Verstovsek S., Kantarjian H., Manshouri T., Cortes J., Giles F. J., Rogers A., et al. Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Blood 2002; 99: 2265–7
   PubMed Web of Science ®Google Scholar
• Mohle R., Green D., Moore M. A., Nachman R. L., Rafii S. Constitutive production and thrombin induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663–8
   PubMed Web of Science ®Google Scholar
• Ruan Guo‐Rui, Liu Yan‐Rong, Chen Shan‐Shan, Fu Jia‐Yu, Chang Yan, Qin Ya‐Zhen, et al. Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice. Leuk Res 2004; 28: 763–9
   PubMedGoogle Scholar
• Korkolopoulou P., Viniou N., Kavantzas N., et al. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study. Leukemia 2003; 17: 89–97
   PubMed Web of Science ®Google Scholar